Bioceros BV-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Bioceros BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011817
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bioceros BV (Bioceros) is a biopharmaceutical company which provides services related to preclinical development of monoclonal antibodies. The company offers GMP-ready protein producing cell lines. The company provides services which include monoclonal antibody generation, cell line and process development, analytical development, manufacturing of recombinant proteins, development and execution of cell-based assays, and consultancy services for immunohistochemistry. The company also provides therapeutic monoclonal antibodies which targets oncology and autoimmune diseases. It serves clients in the Netherlands, the US, the UK, Australia, Scandinavia, Korea, Russia and others. Bioceros is headquartered in Utrecht, the Netherlands.

Bioceros BV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bioceros BV, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bioceros BV, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bioceros BV, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bioceros BV, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Bioceros BV, Pharmaceuticals & Healthcare, Deal Details 9
Private Equity 9
BioGeneration Ventures, Thuja Capital and Forbion Capital Partners Divest Bioceros 9
Licensing Agreements 10
Bioceros Expands Licensing Agreement With Crucell 10
Acquisition 11
Polpharma to Acquire EPIRUS Netherlands from EPIRUS Biopharma 11
Epirus Biopharma Acquires Bioceros for USD14 Million 13
Bioceros BV – Key Competitors 14
Bioceros BV – Key Employees 15
Bioceros BV – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Bioceros BV, Pharmaceuticals & Healthcare, Key Facts 2
Bioceros BV, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Bioceros BV, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bioceros BV, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bioceros BV, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bioceros BV, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
BioGeneration Ventures, Thuja Capital and Forbion Capital Partners Divest Bioceros 9
Bioceros Expands Licensing Agreement With Crucell 10
Polpharma to Acquire EPIRUS Netherlands from EPIRUS Biopharma 11
Epirus Biopharma Acquires Bioceros for USD14 Million 13
Bioceros BV, Key Competitors 14
Bioceros BV, Key Employees 15

★海外企業調査レポート[Bioceros BV-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Brake Bros Ltd:企業の戦略的SWOT分析
    Brake Bros Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • ABPA Holdings Ltd:企業の戦略的SWOT分析
    ABPA Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • InspireMD Inc (NSPR):企業の製品パイプライン分析
    Summary InspireMD Inc (InspireMD) is a medical device company that develops and commercializes embolic prevention systems and neurovascular devices. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for us …
  • Barnes & Noble Education Inc (BNED):企業の財務・戦略的SWOT分析
    Barnes & Noble Education Inc (BNED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Sumitomo Mitsui Construction Co Ltd (1821):企業の財務・戦略的SWOT分析
    Sumitomo Mitsui Construction Co Ltd (1821) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Hollingsworth & Vose Company:企業の戦略的SWOT分析
    Hollingsworth & Vose Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Evonik Industries AG (EVK):製薬・医療:M&Aディール及び事業提携情報
    Summary Evonik Industries AG (Evonik), a subsidiary of RAG-Stiftung, is a specialty chemicals company. Its product portfolio includes surfactants, polymers, resins, additives and others. The company’s products find application in various markets, including adhesives and sealants, automotive, agricul …
  • Gannett Co., Inc.:企業の戦略・SWOT・財務分析
    Gannett Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Gannett Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Warisan TC Holdings Berhad:企業の戦略・SWOT・財務情報
    Warisan TC Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary Warisan TC Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Future Plc (FUTR):企業の財務・戦略的SWOT分析
    Summary Future Plc (Future) is a media company that offers media and digital business solutions various customers. The company offers its services in various areas such as technology, creative, photography and design, games, advertising and film and music. It provides licensing and syndication, expo …
  • Ecobee Inc:電力:M&Aディール及び事業提携情報
    Summary Ecobee Inc (Ecobee) is a thermostat device provider. The company offers ecobee swith plus, ecobee four, ecobee four smarter bundle, ecobee three lite, ecobee three lite smarter bundle, refurbished ecobee three, EMS Si and room sensors. Its products are controlled through voice control and mo …
  • Reece Ltd (REH):企業の財務・戦略的SWOT分析
    Reece Ltd (REH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Vertex Pharmaceuticals Inc (VRTX)-製薬・医療分野:企業M&A・提携分析
    Summary Vertex Pharmaceuticals Inc (Vertex) is a biotechnology company that carries out the discovery, development and commercialization of novel drugs for the treatment of serious and life-threatening diseases. The company offers Orkambi (ivacaftor/lumacaftor) and Kalydeco (ivacaftor) for the treat …
  • Suzuki Motor Corp (7269):企業の財務・戦略的SWOT分析
    Suzuki Motor Corp (7269) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Country Club Hospitality & Holidays Ltd.:企業の戦略・SWOT・財務分析
    Country Club Hospitality & Holidays Ltd. - Strategy, SWOT and Corporate Finance Report Summary Country Club Hospitality & Holidays Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Zest Dental Solutions:医療機器:M&Aディール及び事業提携情報
    Summary Zest Dental Solutions (Zest Dental), formerly ZEST Anchors LLC is a medical device manufacturing company that manufactures, develops, and distributes dental solutions for the treatment of edentulous patients. The company’s products include dental removal tool, attachment processing materials …
  • Capstone Turbine Corporation (CPST):電力:M&Aディール及び事業提携情報
    Summary Capstone Turbine Corporation (CPST) is an energy company. It develops, manufactures, markets, and services microturbine technology solutions and power generation systems. The company integrates air bearing technology, advanced combustion technology, and power electronics to form efficient an …
  • NN Group NV:企業の戦略・SWOT・財務情報
    NN Group NV - Strategy, SWOT and Corporate Finance Report Summary NN Group NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Commonwealth Edison Company:電力:M&Aディール及び事業提携情報
    Summary Commonwealth Edison Company (ComEd) a subsidiary of Exelon Corporation is an electric utility that is engaged in the distribution of electricity to home and business customers. The utility’s business activities include lighting, retro-commissioning, HVAC, new construction, custom projects, i …
  • Endurance Wind Power Inc.-エネルギー分野:企業M&A・提携分析
    Summary Endurance Wind Power Inc. (Endurance) designs, manufactures and markets wind turbines. It offers remote monitoring services through EnduranceRemote Interface Centre (ERIC) proprietary system which provides real-time performance data to check wind speed and monitor the turbine’s operational s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆